Precision BioSciences, Inc.

Historical 13F Holders

Symbol
DTIL
CUSIP
74019P207
All holders as of
Q3 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 74019P207 since 12/18/2024, largest first.

Filer % of Class Filed
Lynx1 Capital Management LP 13G/A
9.9% 11/16/2026
Event 9/30/2026
Readout Capital, LP 13G/A
9.4% 8/14/2025
Event 6/30/2025
Aberdeen Group plc 13G
8.9% 1/27/2026
Event 12/31/2025
Bleichroeder LP 13G/A
8.2% 2/13/2026
Event 12/31/2025
Octagon Capital Advisors LP 13G/A
5.7% 11/3/2026
Event 9/30/2026
BlackRock, Inc. 13G 5.0% 10/27/2026
Event 9/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (7)
Empery Asset Management, LP 13G/A
4.99% 7/29/2026
Event 6/30/2026
Weinstein Benjamin 13G/A 4.0% 8/24/2026
Event 8/21/2026
Novartis Pharma AG 13G/A
3.7% 8/6/2025
Event 6/30/2025
Highbridge Capital Management, LLC 13G/A 3.7% 4/25/2025
Event 3/31/2025
Aquilo Capital Management, LLC 13G/A
0% 8/6/2025
Event 6/30/2025
Janus Henderson Group PLC 13G/A 0% 2/14/2025
Event 12/31/2024
Tang Capital Management LLC 13G/A
0% 2/17/2026
Event 12/31/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 109 19.5 M $122M
2026 Q2 97 17.7 M $139M
2026 Q1 79 16.2 M $88.3M
2025 Q4 70 15.1 M $62.9M
2025 Q3 56 4.65 M $25.7M
2025 Q2 53 4.44 M $18.6M
2025 Q1 49 3.79 M $18.1M
2024 Q4 56 3.88 M $14.7M
2024 Q3 52 3.32 M $29.8M
2024 Q2 48 3.16 M $30.8M
2024 Q1 44 3.16 M $42.8M